Nutricia North America, Inc. – Trademark Portfolio
Entity Type: 03
Nutricia North America, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GLUTARADE, PHENYLADE, and COMPLEX MSD. The owner is based in Rockville, MD.
Suite 100
9900 Belward Campus Dr.
Rockville, MD 20850
Showing of trademarks Trademarks
Trademark Classifications
Nutricia North America, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Nutricia North America, Inc. have?
Nutricia North America, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 3 cancelled.
What trademark classes does Nutricia North America, Inc. file in?
Nutricia North America, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nutricia North America, Inc.'s most well-known trademarks?
Nutricia North America, Inc.'s registered trademark portfolio includes well-known marks such as GLUTARADE, PHENYLADE, and COMPLEX MSD. These are among 3 currently registered trademarks in the portfolio.
What is Nutricia North America, Inc.'s trademark registration success rate?
Nutricia North America, Inc. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.